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During mammalian development, a subpopulation of
endothelial cells in the cardinal vein (CV) expresses lym-
phatic-speciﬁc genes and subsequently develops into the
ﬁrst lymphatic structures, collectively termed as lymph
sacs. Budding, sprouting and ballooning of lymphatic
endothelial cells (LECs) have been proposed to underlie
the emergence of LECs from the CV, but the exact mechan-
isms of lymph vessel formation remain poorly understood.
Applying selective plane illumination-based ultramicro-
scopy to entire wholemount-immunostained mouse
embryos, we visualized the complete developing vascular
system with cellular resolution. Here, we report emer-
gence of the earliest detectable LECs as strings of loosely
connected cells between the CV and superﬁcial venous
plexus. Subsequent aggregation of LECs resulted in for-
mation of two distinct, previously unidentiﬁed lymphatic
structures, the dorsal peripheral longitudinal lymphatic
vessel (PLLV) and the ventral primordial thoracic duct
(pTD), which at later stages formed a direct contact with
the CV. Providing new insights into their function, we
found vascular endothelial growth factor C (VEGF-C) and
the matrix component CCBE1 indispensable for LEC bud-
ding and migration. Altogether, we present a signiﬁcantly
more detailed view and novel model of early lymphatic
development.
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Introduction
Lymphatic vessels, the second vascular system of vertebrates,
are indispensable for tissue homeostasis. The lymphatic
vasculature collects and returns extravasated ﬂuids, proteins,
dietary lipids and immune cells into the venous circulation.
Failure of the lymphatic vessels to develop or function is
associated with a severe impairment of ﬂuid homeostasis,
tissue integrity and the generation of immune responses
(Tammela and Alitalo, 2010; Schulte-Merker et al, 2011).
Although blood and lymphatic vessels exist and operate in
close proximity, it is vital for their function to remain as
separate entities. Both systems only connect at the subclavian
veins, where the thoracic duct (TD) and right lymphatic duct
drain into the venous blood vasculature.
Lymphatic endothelial cells (LECs) differentiate from blood
endothelial cells (BECs) in the cardinal vein (CV) after the
onset of circulation. In the mouse, differentiation of LECs
starts around day 9.0 of embryonic development (E9.0) by
polarized expression of the transcription factor Sox18 in
dorsolateral cells of the CV (Francois et al, 2008), where
Sox18 induces expression of the transcription factor Prox1.
Prox1 becomes detectable in the CV around E10.0 and Prox1-
expressing LECs emerge from the CV and migrate dorsally,
where they form the ﬁrst lymphatic structures (Oliver, 2004).
Prox1-deﬁcient embryos completely lack lymphatic devel-
opment due to a failure in LECs speciﬁcation (Wigle et al,
2002). Acting as a master regulator of lymphatic develop-
ment, forced Prox1 expression in cultured BECs confers
lymphatic identity (Hong et al, 2002; Petrova et al, 2002).
At present, the signals responsible for the polarized
expression of Sox18 and Prox1 in the CV are unknown.
Furthermore, directed migration of the emerging LECs
depends on the vascular endothelial growth factor C (VEGF-C),
which is provided by the lateral mesoderm. Also, Vegf-c /
mouse embryos lack lymphatic vessels and Vegf-cþ / mice
suffer from lymphatic hypoplasia, demonstrating haplo-
insufﬁciency of a single Vegf-c allele for lymphatic
development (Karkkainen et al, 2004). VEGF-C acts via its
tyrosine kinase receptor vascular endothelial growth factor
receptor 3 (VEGFR-3) and the non-signalling coreceptor
neuropilin 2 (Nrp2) (Karpanen et al, 2006; Tammela et al,
2010). Extracellular cues for emerging LECs are provided by
the matrix-interacting protein collagen and calcium-binding
EGF domains 1 (CCBE1), which in a non-cell autonomous
fashion strongly augments the pro-lymphangiogenic activity
of VEGF-C (Bos et al, 2011). In the mouse also CCBE1 is
indispensable for lymphatic development because Prox1-
expressing Ccbe1 / endothelial cells fail to leave the CV
and migrate (Bos et al, 2011).
Elegant genetic studies and lineage tracing experiments
have conﬁrmed the venous origin of LECs ﬁrst proposed by
Sabin over 100 years ago (Sabin, 1902; Wigle and Oliver,
1999; Srinivasan et al, 2007). Yet, despite signiﬁcant advances
*Corresponding author. Department of Vascular Cell Biology, Max
Planck Institute for Molecular Biomedicine, Ro¨ntgenstrasse 20, 48149
Mu¨nster, Germany. Tel.: þ49 251 70365 230; Fax: þ49 251 70365 297;
E-mail: fkiefer@gwdg.de
7These authors contributed equally to this work.
Received: 3 May 2012; accepted: 5 December 2012; published online:
8 January 2013
The EMBO Journal (2013) 32, 629–644
www.embojournal.org  
EMBO
 
THE
JOURNAL
629&2013 European Molecular Biology Organization The EMBO Journal VOL 32 | NO 5 | 2013
in the identiﬁcation of genes involved in the formation of the
ﬁrst lymphatic vessels (reviewed in Schulte-Merker et al,
2011), the exact morphogenetic mechanisms of initial
lymphangiogenesis remain incompletely understood. The
initial analysis of Prox1-deﬁcient mice suggested budding of
newly speciﬁed LECs from the CV, followed by dorsal
migration and reorganization into large lumenized
structures termed as lymph sacs (Oliver, 2004).
Unexpectedly, several genes, some of which are exclusively
expressed in haematopoietic cells (Abtahian et al, 2003;
Bohmer et al, 2010), have been shown to be important for
the separation of blood and lymphatic vessels. These include
the lymphatic transmembrane glycoprotein podoplanin (Fu
et al, 2008; Uhrin et al, 2010) and its pro-coagulant receptor
on platelets, CLEC-2 (reviewed in D’Amico and Alitalo, 2010).
The involvement of platelets in the separation of blood and
lymph vessels sparked a new concept, which proposed LECs
to emerge from the CV by sprouting. Platelet coagulation at
the base of emerging sprouts was hypothesized to trigger the
subsequent abscission of newly formed lymphatic vessels
from the CV (Kim and Koh, 2010; Uhrin et al, 2010). Finally,
optical projection tomography reconstructions suggested
entire segmental areas of the CV to balloon out and pinch
off dorsally. Again aided by platelets, this morphogenetic
process would give rise to lymph sacs in a single step
(Francois et al, 2012). Presently, due to these conﬂicting
models the precise mechanism of the ﬁrst steps of
lymphatic vessel formation remains unclear and requires
novel analytical approaches.
In the mouse, progress in understanding lymphatic devel-
opment has been hampered by limited imaging access. In this
study, we have revisited the ﬁrst steps of lymph vessel
formation using ultramicroscopy, a novel technology based
on selective plane illumination (Becker et al, 2008). We
analysed digital 3 dimensional (3D) reconstructions of
image stacks obtained by optical sectioning of entire,
undistorted embryos. Ultramicroscopy allowed a far more
detailed description of initial lymphangiogenesis compared to
traditional sections, but also the identiﬁcation of previously
unrecognized structures. Here, we show that lymphatic
progenitor cells emerge from the dorsal side of the CV as
streams of cells. LECs rapidly accumulate close to the ﬁrst
lateral branch of the intersegmental vessels, where they
condensate to form a peripheral longitudinal lymphatic
vessel (PLLV), which subsequently gives rise to superﬁcial
lymphatics. Simultaneous with PLLV formation, LECs located
more closely to the CV aggregate to form a large lumenized
structure, which can be considered as the primordial TD
(pTD). In VEGF-C and CCBE1-deﬁcient embryos, Prox1-
positive LEC progenitors were speciﬁed, but displayed
distinct migratory defects. While VEGF-C-deﬁcient LECs
remained stuck inside their venous vessel of origin, loss of
CCBE1 resulted in the formation of aberrant Prox1-positive
sprouts. Unexpectedly, both mutants provided evidence for a
second source of LECs distinct from the CV and located
within the lateral venous plexus.
Results
In this study, we aimed to precisely describe the separation of
the ﬁrst LECs from the CV and therefore visualized this
process in entire, wholemount-stained mouse embryos. To
overcome the limitations associated with the analysis of
consecutive tissue sections, we employed ultramicroscopy,
a technology that has become recently commercially avail-
able. Ultramicroscopy is a planar illumination microscopy
technique, which enabled us to perform optical sectioning
of immunostained, cleared, intact mouse embryos at
E9.5–E12.0. Illumination with a laminar sheet of light causes
the excitation of a thin sample plane, which is recorded
orthogonally to the illumination light path by wideﬁeld
imaging with an area detector, in our case an EM-CCD
camera. Ultramicroscopy is particularly suited for the analy-
sis of developmental processes in large specimen. Because
axial and lateral resolution scale with the inverse numerical
aperture of the illumination and detection optics (1/NAill and
1/NAdet) both parameters can be adjusted to obtain an
isotropic point spread function when using this technology
(Supplementary Figure 1). Despite the use of low magniﬁca-
tion and low numerical aperture optics, image stacks cover-
ing entire wholemount immunostained mouse embryos with
comparable lateral and axial resolution reaching the level of
individual cells were obtained (Figure 1A–D).
The ﬁrst lymphatic endothelial progenitors emerge as
streams of cells from the roof of the CV
To identify landmark structures of the developing vascular
system, we performed wholemount immunostaining for
PECAM-1, which was expressed on all vessels, however,
with varying intensity. Invariably, arterial vessels displayed
the strongest PECAM-1 expression followed by veins, while
the lymphatic vessels showed weakest expression. Therefore,
strong PECAM-1 staining depicted the arterial vasculature in
3D reconstructions, readily identifying prominent structures
like the dorsal aorta (DA), intersegmental arteries (ISA), the
pharyngeal arch arteries (PAA) and the developing heart
(Figure 1A and B). In contrast, VEGFR-3 and the sialomucin
Endomucin predominantly stained venous vessels and were
therefore suitable as surrogate venous markers (Figure 1C
and D). Endomucin expression was particularly pronounced
on small venous vessels and we found its expression main-
tained throughout development while VEGFR-3 expression
was, as described (Kaipainen et al, 1995), downregulated on
venous vessels parallel to the formation of the ﬁrst
lymphatics (see also Supplementary Figure 2; Figure 6I).
Between E9.5 and E12.0 of mouse development, the CV is a
paired, fully symmetrical structure (Figure 1F). Anterior and
posterior CVs are connected via the common cardinal vein
(CCV) from which the sinus venosus (SV) drains venous
blood ventrally to the developing heart (Figure 1E and blue
arrows in F).
We detected the ﬁrst Prox1-expressing (Prox1þ ) ECs at
E10.0 in the CCV, dorsally opposite the SV (Figure 1H, J, L
and M). Simultaneously with the appearance of Prox1þ cells in
the CV, LECs emerged from the dorsal roof of the CV (Figure 1H–
M). Prox1þ cells leaving the CVappeared as streams of spindle
shaped cells (Figure 1J, K, N and O). Because the dorsally
emerging Prox1þ LECs were the ﬁrst discernible LECs outside
the CV, we refer to them as initial LECs (iLECs).
Within the meshwork formed by iLECs, cells were fre-
quently connected by very thin processes (Figure 2A, white
arrowheads). We regularly found erythrocytes, which were
easily discerned by their shape and autoﬂuorescence,
enclosed within arterial and venous vessels of various calibre
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(Figure 2A, red arrowheads), however, we never detected
erythrocytes enclosed by migrating iLECs. Staining for the
endothelial junction protein VE-cadherin suggested that iLECs
were not enclosing a lumen (Supplementary Figure 5G).
Upon egress from the CV, emerging iLECs underwent a
pronounced change in cell shape from squamous to spindle
shape (Figure 2B compare Prox1þ cells in the CV (arrow)
and iLECs). This cellular shape change was accompanied by a
change in nuclear shape from round to oblong (Figure 2D
and E). In addition, the transition was associated with an
upregulation of Prox1, VEGFR-3 and its coreceptor Nrp2 in
iLECs (Figure 2C and F–H).
Concomitantly with the massive appearance of iLECs out-
side the CV, VEGFR-3 expression was lost from venous
vessels (Figure 2B) and was hardly detectable after E11.0.
In contrast, Endomucin expression was maintained on
venous endothelium, but rapidly lost from iLECs and no longer
detectable on LECs after E12.0 (see also Figure 6C and I).
Figure 1 Emergence of the initial lymphatic progenitor cells from the cardinal vein. (A–D) Wholemount immunostaining of the vasculature in
mouse embryos at 9.5/9.75 (A, C) and 10.5 (B, D) days post fertilization. PECAM-1 preferentially stained arterial, Endomucin mostly venous
vessels. Prox1 identiﬁed lymphatic endothelial cells (LECs). The box in (A) delineates the jugular-thoracic region, in which LECs emerged from
the cardinal vein (CV). DA, dorsal aorta; ISA, intersegmental artery; PAAs, pharyngeal arch arteries. Scale bar¼ 100mm. (E) Schematic sagittal
section through one of the paired CVs. Venous ECs, blue; developing heart, dark green. The relative position of the superﬁcial venous plexus
(sVP) is indicated. CCV, common cardinal vein; SV, sinus venosus; H, heart; ISV, intersegmental vein. (F) 3D representation of the paired CCVs
and SV draining into the heart. Depicted on the averted half of the symmetrical CVs are the ISVs and myotomes (M). Blue arrows indicate the
ﬂow of venous blood. (G) Schematic transverse section at the jugular-thoracic region. DA, ISA and arterial plexus in red; CV, ISV and sVP in
blue. NT, neural tube; DRG, dorsal root ganglion; iLECs, initial lymphatic endothelial cells. (H–K) Volume reconstruction of optical sections of
embryos wholemount immunostained for the proteins noted on the left side of each panel. E, developmental stages in days post fertilization.
(H, I, K transverse sections; J sagittal sections). White arrows, emerging iLECs; dotted line, dorsal roof of the CV. Scale bar¼ 100 mm. (L–O)
Schematic depiction of the emergence of the ﬁrst iLECs between E10.0 and E10.25. Prox1þ cells, green with yellow nuclei. The Prox1
expression domain (P1ED) in the averted branch of the CCV is indicated as a green surface.
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Between the developmental stages E10.0 and E10.25, the
number of strongly Prox1þ iLECs dorsally of the CV in-
creased dramatically, resulting in a massive density augmen-
tation of the iLEC meshwork (Figures 1H, K and 2A). During
this process, integrity of the CVwas not impaired and we did
not detect a deformation of or protrusions from the dorsal
roof of the CV (Figures 1J and 2A). At the same time, the
Prox1 expression domain rapidly expanded over the CCV into
the sinus venosus and Prox1 expression was also initiated in
the developing heart (Figures 1N, O and 2D).
Initial LECs condensate to form a PLLV laterally
underneath the myotome
During development, a major branch of the ISAs and inter-
segmental veins (ISVs) extends laterally towards the body
surface. This side branch is located laterally underneath the
myotomes and connects to the superﬁcial capillary plexus
(black arrow in schematic transverse section in Figure 1G).
The majority of iLECs were detected between the CV and
ventral to these major ISA and ISV side branches (Figures 1H,
K, 3A and C), although already at E10.5 iLECs were also
detected more dorsally (Figure 3B).
While we reproducibly detected the ﬁrst Prox1þ cells at
E10.0 in the dorsal roof of the CV, we cannot exclude that
during the subsequent rapid increase iLECs emerged from
other venous vascular beds, in particular the ventral edge of
the superﬁcial venous plexus (sVP) (Figure 1E and G). We
have indicated the relative position of this venous plexus in
Figure 3G and H.
Between the CCV and the ISA/ISV side branches, iLECs
spread cranially and caudally, resulting in a fan-shaped
distribution (Figure 3A). Around E10.5, we observed a
rapid accumulation of LECs at the dorsal edge of the iLEC
meshwork. The iLEC condensation resulted in the formation
of lumenized structures, which upon coalescence formed a
longitudinal vessel in this peripheral position, which we
denoted as PLLV. The corresponding stripe is indicated as
PLLV condensation zone in Figure 3A–D. In contrast to the
DA and CV, the PLLV was rather irregularly shaped along the
longitudinal embryonic axis (note the multiple intersections
with small, lumenized LEC aggregates in the PLLV condensa-
tion zone in Figure 3D). Due to its convoluted shape
(Figure 3B–D), the PLLV is therefore easily missed in thin
optical (Figure 3D) or histological sections.
Simultaneously with the formation of the PLLV, we
observed the appearance of longer, contiguous lymphatic
structures that extended dorsally from the PLLV. We presume
that these LECs subsequently formed the dorsal superﬁcial
lymphatic plexus and refer to them therefore as superﬁcial
LECs (sLECs) (Figure 4B–D). In accord with a migratory or
active sprouting behaviour, sLECs displayed high VEGFR-3
and Nrp2 expression, but in contrast to iLECs showed
strongly reduced Lyve-1 levels (Figure 4I).
The pTD is formed by aggregation of initial LECs close
to the CV
Simultaneously to the condensation of iLECs resulting in
formation of the PLLV, we noted the aggregation of iLECs
Figure 2 Budding of lymphatic endothelial cells from the CV is associated with a change in cell and nuclear shape, but also with a switch in
protein marker expression. (A, B) Sagittal view of the CCVof embryos wholemount immunostained for the proteins indicated on the left side of
each panel. Developmental stages in days post fertilization (E); iLECs, initial lymphatic endothelial cells; cranial, left; caudal, right. Scale
bar¼ 100 mm. Upon egress from the CV, LEC shape changed from squamous (arrows indicate Prox1þ ECs in the roof of the CV) to spindle
shape. White arrowheads, extremely thin connections between iLECs; red arrowheads, erythrocytes frequently found in luminized venous
vessels (but never in iLECs). (B) Also see corresponding scheme Figure 1O. (C) At E10.5, VEGFR-3 and its co-receptor Nrp2 were upregulated in
emerging iLECs, while Lyve-1 levels remained unchanged in the CVand iLECs. ***Pr0.001, NS, non-signiﬁcant. (D, E) Nuclear shape change
from spherical to elliptical associated with the emergence of iLECs. Nuclei of Prox1þ cells outside (red) and within (green) the CCV were
depicted by nuclear surface rendering (D) and plotted against sphericity and ellipticity (prolate) (E). Scale bar¼ 100mm. (F–H) Surface
rendering of Prox1þ nuclei inside and outside the CCV of wholemount immunostained embryo in sagittal (F) and transversal view (G, H).
(F, G) Prox1 expression strength is indicated by pseudo-colouring using a heat map, i.e. highest Prox1 expression is indicated in red, low
expression in blue. (H) Anatomical location of cells is depicted by superposition. Software package: Imaris Vantage, Scale bar¼ 100mm.
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more closely located to the CV (Figure 4A, white arrow-
heads). Between E10.5 and E11.0, this process proceeded
rapidly and resulted in the appearance of agglomerates or
nests of iLECs, which also lumenized and gave rise to a larger
structure. This newly formed lymphatic vessel was clearly
separate from the PLLVand it developed in close proximity to
the CV, to which it actually had physical contact (Figure 4B
and E–H). Towards its cranial end, it was connected via a
bow-shaped structure with the PLLV (Figure 4B, C and E–H).
These unique properties were highly reminiscent of the TD,
which at completion of fetal development, constitutes the
largest lymphatic vessel. The pTD develops anatomically in a
position corresponding to the location of the mature TD.
Therefore, we suggest referring to the largest, lumenized,
embryonic lymphatic structure with direct physical contact to
the CV as pTD (Figure 4B–D). At developmental stage E11.5,
the pTD was fully developed and while dorsally sprouting
sLECs originated from the PLLV, more laterally directed
sprouts emanated preferentially from the pTD (Figure 4C
and D). We would like to emphasize that at midgestation
and during early fetal development both PLLV and pTD
constitute bilateral, fully symmetrical structures.
High levels of Prox1 expression at the contact site of
pTD and CV
We were particularly intrigued by the tandem contact sites
that stereotypically formed between each pTD and the CCV.
Starting at E11.5, these contact points were readily identiﬁed
Figure 3 iLECs condense at the level of the major lateral branch of the intersegmental vessels to form a lumenized peripheral longitudinal
lymphatic vessel (PLLV). (A–D) Sagittal view reconstructed from optical sections of embryos wholemount immunostained for the proteins
indicated above each panel. E, developmental stages in days post fertilization; cranial, left; caudal, right. (A) During the ﬁrst stages of iLECs
emergence, iLECs appeared in a fan-shaped pattern, which extended caudally and cranially from the CCV. Dotted line, ventral border of iLEC
detection. (A–D) iLECs immediately condensed at the level of the ﬁrst lateral branch of the intersegmental vessels to form the PLLV. Long-
hatched lines denote the position of the CCV and SV; short-hatched line, area of iLECs condensation and PLLV formation. (E–H) Schematic
depiction of the position of iLECs appearing dorsal to the CV between E10.5 and E10.75. Prox1þ iLECs outside the CCV are depicted in light
green, Prox1þ cells within the CV and heart muscle in dark green. The Prox1 expression domain (P1ED) in the averted branch of the CCV is
indicated as a light green surface. Position of the superﬁcial venous plexus, as a possible alternative source of iLECs, is indicated in blue (G, H).
Prox1þ endothelial cells within the sVP are highlighted in red. sVP, superﬁcial venous plexus; scale bars¼ 100 mm.
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by their exceptionally high Prox1 expression (Figure 5A and
B, white arrowheads). While we had noted that Prox1 was
upregulated in migrating iLECs after egress form the CV,
Prox1 expression decreased again upon aggregation and
incorporation of iLECs into the pTD, albeit the pTD clearly
remained Prox1þ . In contrast, sLECs of the developing
dorsal and lateral superﬁcial lymphatics retained high
Prox1 expression, however as previously described
(Norrmen et al, 2009), completely lost Lyve-1 expression.
By far the strongest Prox1 expression was detectable in the
LECs at the contact site between pTD and CV (Figure 5A–E,
white arrowheads). At E12.0, Prox1 was no longer expressed
in the CCV or SV, with exception of the ECs directly opposing
the pTD (Figure 5E, arrows). Both, the ECs of the CCVand the
pTD, strongly expressed Prox1, hence, the immediate contact
site was formed by a double layer of highly Prox1þ ECs
(Figure 5E). Intriguingly, the tandem contact sites between
pTD and CCV always ﬂanked an arterial vessel, which
transverses the CV (Figure 5B–E, white asterisk). This arterial
vessel, which we identiﬁed as a side branch of the developing
subclavian artery (Supplementary Figure 3; Supplementary
Video 1), was in direct contact with the CV (Figure 5E).
Starting at day E12.0, we often detected densely packed
erythrocytes within the lumen of the pTD adjacent to the CV
(Figure 5C, red arrowhead), suggesting the development of a
direct connection between both structures. Based on this
Figure 4 LECs between the CV and PLLV aggregate and form increasingly larger lumenized structures ﬁnally giving rise to the primordial
thoracic duct. (A–C) Sagittal and (D) transversal views reconstructed from optical section of embryos wholemount immunostained for the
proteins indicated above each panel. (A) Arrowheads indicate rapid and progressive aggregation of LECs located between CVand PLLV, which
resulted in the formation of a large lumenized structure, the pTD (B–D). (C, D) Superﬁcial lymphatics (sLECs) appeared to sprout from the
PLLV dorsally and the pTD laterally. PLLV and pTD were connected at the cranial end of the pTD. (F–H) Schematic depiction of the cellular
aggregation/condensation events that result in pTD formation. (I) At E11.5, VEGFR-3 and its co-receptor Nrp2 were upregulated in sLECs, while
Lyve-1 levels were strongly reduced as compared to the CVand iLECs. ***Pr0.001. Developmental stages in days post fertilization (E); cranial,
left; caudal, right. ACV, anterior cardinal vein; CCV, common cardinal vein; PCV, posterior cardinal vein; ISV, intersegmental vein; PLLV,
peripheral longitudinal lymphatic vessel; pTD, primordial thoracic duct; sLECs, superﬁcial lymphatics. Scale bars¼ 100 mm.
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frequently recurring observation and the high expression of
Prox1, we speculate that the contact sides between pTD and
CV might develop into ﬁrst valves, allowing the developing
lymphatics to become functional by preventing backﬂow
from the venous circulation into the nascent lymphatic
vasculature.
Distinct gene expression patterns characterize different
LEC populations
To obtain further insight into the molecular mechanisms
regulating the ﬁrst steps of lymph vessel development, but
also to validate our wholemount analysis, we stained for the
expression of cell surface markers or secreted proteins known
to be important for vascular development. Suitable antibodies
for wholemount staining were only available for some proteins,
therefore, we evaluated immunostaining of cryosections in
parallel (results are summarized in Figure 6I). As expected, in
most sections it was not possible to identify the PLLV unam-
biguously. Therefore, we distinguished Prox1þ ECs within the
CV from emerging iLECs and LECs within the lumenized pTD
from sLECs of the forming superﬁcial lymphatics.
The transmembrane glycoprotein podoplanin (Pdpn) is
expressed within the vascular system in a lymphatic-speciﬁc
manner (Schacht et al, 2003) and has been identiﬁed as a
Figure 5 Paired contact sites between the newly formed pTD and the CVare characterized by highest levels of Prox1 expression. (A–C) Sagittal
views of wholemount immunostained embryos. The newly forming pTD rapidly consolidated into a massive lumenized structure, cranially
connected in a U-shape to the PLLV (left side A, B). Two contact sites between CVand pTD expressed high levels of Prox1 (arrowheads). (B–E)
An arterial vessel identiﬁed as a transient side branch of the subclavian artery and stereotypically located between the contacts of pTD and CV
is marked by an asterisk. (C) Red arrowhead: packed erythrocytes within the pTD. Arrows denote Prox1þ cells in the CV opposing the pTD
contact sites. (D, E) Individual planes (optical sections) through the contact area of pTD and CV. (F–H) Schematic representation of the
development of the contact sites between pTD and CVwith highly Prox1þ cells at the contact site depicted in dark green with red nuclei. Scale
bars¼ 100mm.
Visualizing ﬁrst lymph vessels by ultramicroscopy
R Ha¨gerling et al
635&2013 European Molecular Biology Organization The EMBO Journal VOL 32 | NO 5 | 2013
Visualizing ﬁrst lymph vessels by ultramicroscopy
R Ha¨gerling et al
636 The EMBO Journal VOL 32 | NO 5 | 2013 &2013 European Molecular Biology Organization
surface-bound ligand for the platelet C-type lectin CLEC-2
(Suzuki-Inoue et al, 2007). Pdpn-mediated CLEC-2 activation
is pro-coagulant and essential during the separation of blood
and lymphatic vessels (Uhrin et al, 2010). In agreement with a
recent study (Francois et al, 2012), we detected no Pdpn
expression on Prox1þ cells in the CV. Moderate Pdpn
expression started at E11.0 on the nascent pTD and sLECs,
while iLECs remained negative (Figure 6A–I; Supplementary
Figure 4). By E11.5, Pdpn was strongly expressed on all
lumenized and peripheral lymphatic structures.
A second common marker of adult peripheral lymphatics,
in particular lymphatic capillaries, is the hyaluronan receptor
LYVE-1. As described (Norrmen et al, 2009; Tammela et al,
2010), we found strong, polar expression of Lyve-1 on
Prox1þ cells in the dorsal half of the CV, which was
maintained on the emerging iLECs and nascent lumenized
structures (pTD) (Figure 6D and I; Supplementary Figure 4A,
B, D and E). Lyve-1 was not or only weakly detectable on
sLECs (Figure 4I), however, it was again found re-expressed
on skin lymphatics at E14.5 (not shown).
Netrins, laminin-related, secreted axon guidance molecules
and their Unc receptors are involved in patterning during
vessel growth (Adams and Eichmann, 2010). Hence, we were
particularly interested to analyse the expression of Netrin-4, a
pro-lymphangiogenic factor (Larrieu-Lahargue et al, 2010), on
emerging lymphatics. Netrin-4 was expressed on blood vessels,
but not on iLECs or sLECs. Lymphatic Netrin-4 expression
started around E11.5 on the pTD (Figure 6F; Supplementary
Figure 6E–H). In contrast, the canonical netrin receptor Unc5B
was expressed on the pTD and sLECs starting at E11.0
(Figure 6G and H; Supplementary Figure 7). The pro-lymphan-
giogenic activity of Netrin-4 appears to be mediated by integ-
rins, in particular integrin a6b1, rather than Unc receptors
(Larrieu-Lahargue et al, 2011). We therefore tested the
presence of a6 integrins on LECs and found it
homogeneously expressed on lumenized structures and sLECs
from E11.0 onwards (Figure 6E; Supplementary Figure 6A–D)
while integrin b1 was present on all Prox1þ LECs at E10.5 and
E11.5 (Supplementary Figure 6M–P). Surprisingly, we did not
detect integrin a9 expression on Prox1þ LECs at E10.5 and
E11.5, while using the same reagents and protocol a9 was
clearly present on the pTD at E13.0 on developing lymphove-
nous valves (Supplementary Figure 6Q–T).
VEGFR-3 is necessary for proper pTD formation and
sLEC patterning
While the receptor tyrosine kinase VEGFR-3 is indispensable
for blood vascular development, it is also a key regulator for
lymphangiogenesis (Tammela et al, 2008). Mice deﬁcient for
VEGFR-3 die at E10.5 at the onset of lymphangiogenesis due
to cardiovascular defects (Dumont et al, 1998). Therefore and
in the absence of an inducible VEGFR-3 knockout, our
analysis was limited to heterozygous embryos. In Vegfr3þ /
embryos the main lymphatic structures PLLV, pTD and sLECs
formed (Supplementary Figure 9F). Also formation of the
contact sites between CV and pTD appeared unimpaired
(Supplementary Figure 9F, G and I). However, consistent
with monoallelic VEGFR-3 expression, iLEC numbers outside
the CV were reduced (Supplementary Figure 9F) and the
sLECs meshwork was mispatterned. Y-shaped sLEC struc-
tures, which were frequently detected in wild-type litter-
mates, were absent in Vegfr3þ / embryos (Supplementary
Figure 9B and G). Most prominently, the pTD appeared
disrupted and of smaller diameter (Supplementary
Figure 9D and I).
CCBE1 deﬁciency results in a failure of nascent LECs to
leave the veins, formation of aberrant venous sprouts
and a lack of developing lymphatic vessels
CCBE1 is an extracellular matrix component essential for
lymphatic vessel development. Genetic ablation of CCBE1
results in the loss of deﬁnitive lymphatic structures in the
mouse and zebraﬁsh (Bos et al, 2011). From LacZ-
wholemount stainings of mouse embryos, we concluded
that CCBE1 is expressed in areas associated with lymphatic
development from E10.5 onwards (Supplementary Figure 10).
At day E10.5, Prox1þ ECs developed in the CV of Ccbe1 /
embryos (Figure 7B, D and F). The expression domain of
Prox1 appeared to extend into the ISVs and Prox1þ cells
accumulated in the CV. More unexpected, we also found
Prox1þ /VEGFR-3þ cells in a rudimentary form of the
PLLV, while the iLEC meshwork between CV and PLLV was
completely absent (Figure 7B, D and F). Prox1þ LECs, which
aligned at the PLLV condensation zone, were part of aberrant
sprouts that originated from the intersegmental vessels, but
also from the ventral edge of the sVP (Supplementary
Figure 11C and D). Also from the CV, Prox1þ /VEGFR-3þ
cells formed dilated sprouts or bag-like sacs, which always
remained connected with the CV (Figure 7B, D and F;
Supplementary Figure 11A–D; Supplementary Video 2).
While at E10.5 the observed dysmorphic sprouts were highly
Prox1þ , 1 day later at E11.5, Prox1 expression was unde-
tectable in Ccbe1 / embryos (Figure 7F and G;
Supplementary Figure 11E). The PLLV rudiment was no
longer detectable, however, there were still sprouts projecting
from the ISVs (Figure 7F and G). Prox1 expression was also
Figure 6 Different lymphatic endothelial cell populations express distinct sets of marker proteins. (A–G) Immunostainings of transversal
cryosections from embryos at the indicated developmental ages are shown. Visualized antigens are depicted in the corresponding colours
indicated above each panel. Panels exemplify representatively the marker expression summarized in (I). (A) Podoplanin expression was absent
on LECs at E10.0, was ﬁrst detectable at E11.0 (arrowheads) and was abundant on LECs at E12.0. Note Prox1þ cells in the CVwere negative at
all stages. (B) At E11.5, Nrp2 was moderately expressed on the CV and the pTD, while iLECs emerging outside the CV were strongly positive
(arrows). (C) Endomucin was only transiently retained on iLECs. (D) Lyve-1 was strongly expressed on Prox1þ ECs of the CV and the pTD,
while sLECs showed only residual expression (arrowheads). (E) Integrin a6 was moderately expressed on all vascular structures. (F) At E11.5,
Netrin-4 was expressed strongly on BECs (arrows), weakly on the CVand moderately on the pTD, but was undetectable on iLECs (arrowheads).
(G, H) Unc5B was strongly expressed on iLECs (G, arrowheads) and sLECs (H, arrowheads), while it was weak on the pTD. (H) Sagittal
projection reconstructed from optical sections of a wholemount immunostained embryo for Prox1 (green) and Unc5B (blue). (I) Expression of
the indicated proteins in different LEC populations during midgestation. Data are based on either immunostained cryosections or wholemount
immunostaining. Indicated structures and cell populations: CV, cardinal vein; iLECs, initial LECs (ﬁrst wave of LECs emerging from the CV as
spindle shaped, loosely connected cells); sLECS, superﬁcial LECs (LECs extending from the PLLV (dorsally)); pTD, primordial thoracic duct.
CV*, expression limited to Prox1þ cells on the dorsal side of the CV. Scale bars¼ 100 mm.
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lost from the CV and the underlying developing heart.
Notably, VEGFR-3 appeared strongly upregulated in venous
vessels (Figure 7E and G) and in the malformed sprouts,
which protruded from the ISVs over the entire length of the
CCV (Supplementary Figure 11E). We detected several in-
stances where irregular longitudinal sprouts appeared to form
connections between the ISVs.
In VEGF-C-deﬁcient mice, LECs remain trapped in the
venous vasculature, revealing their origin
VEGF-C has been shown to be indispensable for the mobili-
zation of LEC progenitors from their venous origin
(Karkkainen et al, 2004). For instance, in Vegfc / mice
Prox1þ LECs fail to migrate from the CV. When we analysed
VEGF-C-deﬁcient embryos by ultramicroscopy, we detected at
E10.75 a rich accumulation of Prox1þ LECs in the CCV,
while there were no iLECs detected outside the CV
(Figure 8D–F). Like previously observed in Ccbe1 /
embryos, VEGFR-3 expression in the ISVs and sVP was
elevated (Figure 8C and E). Remarkably in Vegfc /
embryos, we detected a venous vessel at the ventral edge of
the sVP, which massively contained Prox1þ cells (Figure 8E
and F, white arrowhead), strongly supporting our previous
suspicion that also the ventral edge of the sVP is a source of
LEC progenitors (Supplementary Video 3).
CCBE1 and VEGF-C interact synergistically during
directed migration of iLECs
In addition to its function in lymphatic development, CCBE1
has been described to increase the pro-lymphangiogenic
Figure 7 CCBE1 deﬁciency results in a failure of Prox1þ cells to separate from the CV and in rapid loss of nascent lymphatic structures.
(A, B, F, G) 3D reconstructions of wild-type (A) and Ccbe1 / (B, F, G) embryos, wholemount immunostained for the indicated proteins.
(A, B) Sagittal view at E10.5. (B) In CCBE1-deﬁcient embryos, abundant Prox1þ cells were detected in the CV and in a rudimentary PLLV,
adjacent to the superﬁcial venous plexus. In contrast to wild-type embryos (A), the meshwork of spindle shaped iLECs between CCVand PLLV
was absent. (B, F) Prox1þ cells outline the CCV and SV, while atypical, large, lumenized sprouts emerged from the CV (arrowheads).
(G) Highly VEGFR-3þ , dysformed sprouts extended from the CV (arrowheads) and ISVs (arrow). (C–E) Schematic representation of Prox1þ
cells in wild-type (C) and CCBE1-deﬁcient (D, E) embryos. Strongly VEGFR-3þ venous endothelium is depicted in dark blue. sVP, superﬁcial
venous plexus; scale bars¼ 100 mm.
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activity of VEGF-C in the mouse (Bos et al, 2011). Therefore,
we decided to analyse developing mouse embryos of Ccbe1
and Vegfc compound heterozygotes. Wholemount
immunostainings of Vegfcþ / at E10.5 revealed a reduced
number of Prox1þ iLECs outside the CV (Figure 9D–F),
while Ccbe1þ / embryos in addition showed an irregular
formation of ISVs and Prox1-positive, lumenized sprouts
extending from the dorsal roof of the CV (Figure 9G–I). In
spite of this early phenotype, CCBE1 heterozygous mice
developed normally and showed no lymphatic phenotype at
later developmental stages (not shown). In double hetero-
zygous littermates, the reduction of iLECs, but also the
formation of aberrant sprouts and abnormal ISV formation
were exacerbated, indicating a synergistic interaction of both
pathways (Figure 9J–L).
Discussion
Signiﬁcant progress in the understanding of the molecular
control of lymphangiogenesis has to date implicated 420
genes in the control of lymphatic vessel growth and beha-
viour (Tammela et al, 2010; Schulte-Merker et al, 2011).
Lineage tracing experiments using genetically modiﬁed
mice provided direct evidence for a venous origin of the
lymphatic endothelium (Srinivasan et al, 2007), yet a precise
description of the morphogenetic events during the
separation of the emerging lymphatic from venous
endothelium is still missing. To obtain a precise
understanding of this process, we applied optical sectioning
of cleared wholemount immunostained mouse midgestation
embryos, using the planar illumination technique
ultramicroscopy (Becker et al, 2008). Volume reconstruction
of the obtained image stacks allowed a comprehensive
analysis, which provided by far more detail than
immunostained serial sections.
Based on the existing literature, we started our analysis
with E9.5 mouse embryos and ﬁrst detected polarized Prox1
expression in ECs of the dorsal roof of the CCV at E10.0.
Between E10.0 and E10.5, we observed a rapid expansion of
the Prox1 expression domain over the entire CCV, also
extending into the SV. Simultaneously, Prox1 expression
was initiated in the developing heart and ﬁnally also detected
at the ventral edge of the sVP.
The onset of Prox1 expression in the CCV coincided with
the emergence of the ﬁrst Prox1þ LECs, which we termed as
‘initial LECs’ or iLECs, outside the CCV. iLECs emigrated from
the CCV as strings of cells and rapidly reorganized into a
meshwork. Characteristic changes in cell shape from squa-
mous to spindle shaped, along with the upregulation of
Prox1, VEGFR-3 and Nrp2, suggest that LECs upon emigra-
tion from the CCV undergo a transition towards a more
migratory phenotype. Prox1 has been shown to regulate
expression of LEC-speciﬁc genes, including VEGFR-3 and
Nrp2 (Hong et al, 2002; Petrova et al, 2002) and VEGFR-3
has been suggested to enhance migration of LECs. Shape
change and highly motile behaviour associated with high
Prox1 expression have been attributed to a Prox1-mediated
upregulation of integrin a9b1 (Mishima et al, 2007),
which can also function as a receptor for VEGF-C and D
(Vlahakis et al, 2005). VEGF-C, probably the most important
VEGFR-3 ligand in the context of lymphatic vessel forma-
tion, is indispensable for the migration of iLECs. In
VEGF-C-deﬁcient mice, Prox1-expressing LEC progenitors
arise but fail to leave the CV (Karkkainen et al, 2004). Our
results indicate that this is true for all venous vessel beds, and
therefore Vegfc / mice provide an elegant trapping tool to
identify venous sources of LEC differentiation. Using this
approach, we identiﬁed the lower edge of the sVP as a
previously unidentiﬁed source of LECs. Given the close
physical proximity of this structure to the forming PLLV, it
is tempting to speculate that parts or even the entire PLLVare
derived from iLECs emerging from the sVP, while the pTD is
most likely formed by CCV-derived iLECs.
Presently, the analysis of mouse midgestation embryos via
ultramicroscopy is limited to ﬁxed samples, which have been
chemically cleared to become highly transparent (Mertz,
2011). Therefore, we were not able to dynamically visualize
the emerging iLECs. The rapid appearance of massive
numbers of iLECs between E10.0 and E10.5 was surprising
in view of the comparatively low and constant EdU
incorporation of Prox1þ cells between E9.5 and E11.5
(Supplementary Figure 8). Therefore, our analysis is more
compatible with a massive and synchronous emigration of
iLECs from veins than with high local proliferation and in this
respect also argues for additional sources of iLECs besides the
CCV. Still the CCV is the ﬁrst and likely also most important
source of iLECs. Furthermore, we conclude from the fact that
we were only able to locate Prox1þ cells unequivocally in
superﬁcial veins when using mutant Vegfc / or Ccbe1 /
mice that once these cells arise they leave the veins rapidly.
The absence of erythrocytes enclosed by iLECs, but also
VE-Cadherin-GFP stainings of cryosections (Supplementary
Figure 5G and H), strongly suggested that emerging iLECs are
not connected by a patent lumen with the CV. Therefore, our
data argue against a separation of LECs from the CV by
sprouting. The detection of iLECs was clearly not associated
with the appearance of lumenized lymphatic structures con-
tiguous with the CV. In contrast, our analysis, in accord with
a most recent publication (Yang et al, 2012), supports a model
of budding and emigration of individual iLECs from their
venous sources.
In this respect, Ccbe1 / embryos behaved remarkably
different. Consistent with a recent description (Bos et al,
2011), we observed the apparently normal differentiation
and accumulation of Prox1þ ECs in the CCV of CCBE1-
deﬁcient embryos. Providing new insight into this
phenotype and in contrast to wild-type littermates, we
detected the appearance of highly irregularly shaped
sprouts of Prox1þ ECs from the CV, the ISVs and the
endothelium of the sVP. While both mouse strains
completely lack iLECs, the aberrant sprout formation clearly
distinguished CCBE1 from VEGF-C-deﬁcient mice. In Ccbe1 /
embryos, the Prox1 expression domain in the CCV was
caudally and cranially extended and now also reached deep
into the ISVs. At E10.5, Prox1þ ECs accumulated in the CCV,
probably a consequence of their inability to bud. Surprisingly,
Prox1 expression was rapidly lost within the next 24 h and
subsequently neither detectable in ECs, nor in the developing
heart. In contrast, venous EC failed to downmodulate
VEGFR-3 expression, which remained unusually high,
while numerous aberrant sprouts formed along the entire
length of the CV (Figure 7G). During this massive, aberrant
sprout formation, VEGFR-3 likely provides and integrates
migratory as well as directional cues, while CCBE1 appears
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indispensable for the egress of individual iLECs from the
venous cell collective.
Both Vegfr3 and Vegfc heterozygosity most prominently
resulted in a reduction of iLECs emerging between the CV
and sVP, in accord with the notion that VEGF-C is the
predominant VEGFR-3 ligand and VEGFR-3 the most relevant
VEGF-C receptor during initial lymphangiogenesis.
Somewhat unexpected, we detected malformations of the
ISVs and a reduced capacity of iLECs to separate from the
CV in Ccbe1þ / embryos. These defects are corrected during
further development, because analysis of late gestation
Ccbe1þ / fetuses or neonates revealed no abnormalities. In
Vegfc/Ccbe1 compound heterozygotes, these defects were
aggravated demonstrating that both factors synergize during
initial lymphangiogenesis.
The exceptional capacity of ultramicroscopy to reveal
complex spatial structures enabled us to describe, for the
ﬁrst time, two separate lymphatic vessels, which have so far
been collectively referred to as lymph sacs. Unexpectedly, we
detected a ﬁrst condensation zone of iLECs at the level of the
major lateral intersegmental vessel branch, resulting in a
lumenized structure that roughly followed the longitudinal
axis of the embryo, the PLLV. The PLLV is difﬁcult to spot in
histological sections, reiterating the strength of and the need
for optical sectioning approaches. A second, large lumenized
structure, the pTD, formed more ventrally close to the CV
likely by coalescence of lumenized nests of iLEC aggrega-
tions. Incorporation of LECs into the pTD was accompanied
by a coordinate downregulation of Prox1, VEGFR-3 and Nrp2,
probably reverting the expression changes that we noted
upon egress of iLECs from the CCV.
Junction formation and EC polarization are essential com-
ponents of vascular lumen formation (Axnick and Lammert,
2012). Several mechanisms of lumen formation have so far
Figure 8 Prox1þ endothelial cells in VEGF-C-deﬁcient mouse embryos are unable to leave their vessels of origin and thereby mark the venous
sources of LECs. 3D reconstruction of (A, B) wild-type and (C–F) Vegfc / embryos, wholemount immunostained for the indicated proteins at
E10.75, sagittal view. In VEGF-C-deﬁcient embryos, Prox1þ endothelial cells were unable to leave venous vessels resulting in an absence of
developing lymphatic structures. (E, F) Besides Prox1þ cells in the CV (arrow), a second population of Prox1þ lymphatic progenitors is
trapped in a larger venous vessel at the ventral edge of the sVP (arrowhead). (G, H) Schematic representation of Prox1þ cells in wild-type (G)
and VEGF-C-deﬁcient (H) embryos NE, stripe of neuronal Prox1 expression; sVP, superﬁcial venous plexus, scale bars¼ 100mm.
Figure 9 CCBE1 and VEGF-C interact synergistically during iLEC egression and lymph vessel formation. 3D reconstructions of wild-type
(A–C), Vegfcþ / (D–F), Ccbe1þ / (G–I) and Vegfcþ //Ccbe1þ / (J–L) embryos, wholemount immunostained for the indicated proteins at
E10.5, sagittal view. CCVand roots of the ISVs are indicated by dashed lines, Prox1þ cells by arrows. Compared to wild-type littermates (A–C)
Vegfcþ / embryos showed a reduction of emigrating iLECs from the CCV (D, E). Contrary to this, in Ccbe1þ / embryos an impaired formation
of ISVs was detectable. In addition, atypical, lumenized sprouts appeared at the roof of the cardinal vein that were Prox1þ and expressed high
levels of VEGFR-3 (G–I). (J–L) In compound heterozygous embryos, this phenotype was grossly exaggerated indicating a synergistic role of
VEGF-C and CCBE1 during lymphatic vessel formation. Scale bars¼ 100mm.
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been described including cell hollowing (Kamei et al, 2006),
chord hollowing (Strilic et al, 2009), junctional
rearrangement between cells (Blum et al, 2008) and
selective sprouting (Herbert et al, 2009). Our analysis
suggests that PLLV and pTD lumen formation is preceded
by iLEC aggregation and although loosely reminiscent of
chord hollowing, probably different from the mechanisms
described for blood vessels. The newly formed lymphatic
vessels have a fundamentally different structure compared to
the DA and CV. PLLVand pTD are more irregular in shape and
of far larger calibre than blood vessels. Therefore, it is likely
that additional and unique processes are involved in
lumenization following the aggregation of iLECs.
The formation of two initial longitudinal lymphatic vessels
bears a distant resemblance to the formation of the zebraﬁsh
lymphatic trunk vasculature, where LECs directly bud from
the posterior CV. Sprouts that do not connect to primary
intersegmental vessels (forming veins in the process),
migrate to the horizontal myoseptum where they arrange as
a string of parachordal lymphangioblasts (PLs) (Hogan et al,
2009; Bussmann et al, 2010). Guided by ISAs, PLs then move
dorsally and ventrally to form the dorsal longitudinal
lymphatic vessel and the TD, which is ventrally located
between DA and CV. To which extend these structures are
related to the PLLV and pTD remains to be investigated.
A notable exception to the downregulation of Prox1 in
large lumenized structures were the contact areas between
pTD and CV. High level Prox1 expression has previously been
described to be a hallmark and indispensable for lymphove-
nous valve formation (Srinivasan and Oliver, 2011; Sabine
et al, 2012). Based on this property, the anatomical position
and the frequent occurrence of packed erythrocytes in the
pTD close to the contact areas with the CV, we concluded that
these sites might give rise to the ﬁrst lymphovenous valves.
The contact sites between pTD and CV always ﬂanked a side
branch of the subclavian artery, which crossed the CV at this
position. It is an interesting possibility to consider an
inductive function of this artery for lymphovenous valve
formation. VEGFR-3 heterozygosity apparently did not
interfere with ordered lymphovenous valve formation. We
should note in this context that our analysis revealed VEGFR-2
expression in the pTD but also weakly in the CVat the time of
primordial valve formation (Figure 6I), which might com-
pensate for the loss of VEGFR-3. Interestingly, we had de-
tected robust VEGFR-2 expression earlier in the CVand iLECs.
The axon guidance receptor Unc5B has recently been
demonstrated to signal vascular integrity in blood ECs
(Koch et al, 2011). We found Unc5B expressed on the PLLV,
pTD and the newly forming sLECs where it might contribute
to structural maintenance during the formation of the
lymphatic system. Whether the endothelial-speciﬁc Robo
family member Robo4, which acts as a counter receptor for
Unc5B in blood ECs is expressed in developing LECs remains
to be investigated. Interestingly, the canonical Unc5B ligand
Netrin-4 was only expressed on the PLLV and pTD. Netrin-4
acts pro-lymphangiogenic, however, these effects are, at least
in vitro, not mediated by Unc5B, but by the integrin a6b1
(Larrieu-Lahargue et al, 2010, 2011). We found the a6 and b1
chains widely expressed on the PLLV, pTD and sLECs,
suggesting that integrin a6b1 is generally of importance for
developing LECs. In line with this assumption, integrin b1
was recently shown to transduce mechanical forces from
tissue ﬂuid accumulations and to be required for the
resulting VEGFR-3 tyrosine phosphorylation, LEC
proliferation and lymph vessel expansion (Planas-Paz et al,
2012). Being selectively expressed on the PLLV and pTD,
Netrin-4 might confer the speciﬁc ability for large lumen
formation within the newly forming lymphatic system.
Whether Unc5B signals via Netrin-4 during lymphatic
development remains to be investigated.
In summary, based on optical sectioning microscopy of
wholemount immunostained mouse embryos, here we
describe in detail structures that have previously collectively
been referred to as lymph sacs. We have identiﬁed four
hallmarks of initial lymphatic vessel formation: (1) iLECs
emerge from the roof of the CV, but also from additional
venous sources as streams of connected cells, forming a
meshwork. (2) iLECs coalesce to lumenized structures at
the ﬁrst lateral intersegmental vessel branch to form the
PLLV; sLECs sprouting from the PLLV form dorsal superﬁcial
lymphatics. (3) A second large lymphatic structure, the pTD
forms from iLEC aggregates close to the CV; lateral sLECs
extend from the pTD. (4) Two areas of highest level Prox1
expression demark the sites of closest juxtaposition between
the CVand pTD and likely give rise to the ﬁrst lymphovenous
valves.
The application of optical sectioning microscopy promises
to provide further unexpected insights into the development
of vascular structures. An important challenge will be
the development of methods to image living embryos and
directly observe migrating cell populations.
Materials and methods
Mouse strains
Wild-type, CCBE1LacZ/LacZ (Bos et al, 2011), VEGFR-3LacZ/LacZ
(Dumont et al, 1998) mouse embryos of C57Bl/6 genetic
background and VEGF-CLacZ/LacZ (Karkkainen et al, 2004) mouse
embryos of CD1 background were analysed at different
developmental stages between E9.5 and E12.5. Embryonic staging
(E) was determined by the day of the vaginal plug (E0.5). All animal
experiments were approved by the Animal Experimentation
Committee of the county of Mu¨nster and the Federal Ministry of
Nature, Environment and Consumer Protection, North Rhine
Westphalia.
Ultramicroscopy
After immunoﬂuorescence wholemount staining, optically cleared
embryos were imaged on a LaVision Ultramicroscope (LaVision
BioTec, Bielefeld). Stacks were captured with a step size of 1mm and
at different magniﬁcations. 3D reconstruction, morphometric ana-
lysis and analysis of ultramicroscopy stacks were performed by
using IMARIS and IMARIS Vantage software (Version 7.6.0,
Bitplane).
Immunoﬂuorescence embryo wholemount stainings
Embryos were dissected and ﬁxed for 4 h in 4% PFA/PBS at 41C.
Prior antibody staining samples were permeabilized (0.5% Triton
X-100/PBS) and subsequently blocked in PermBlock solution (1%
BSA, 0.5% Tween-20 in PBS). Embryo wholemount stainings were
performed by using anti-PECAM-1, anti-VEGFR-3, anti-Prox1, anti-
Unc5B and anti-Endomucin as primary antibodies and Alexa-dye
coupled secondary antibodies (Invitrogen) diluted in PermBlock.
Following each staining step, samples were washed three times in
PBS-T (0.5% Tween-20/PBS).
Optical clearing
For visualization, embryo wholemount stainings were embedded in
1% low-melting point agarose. After dehydration in methanol
(50%, 70%, 95%, 100%, 100% methanol, each step 30minutes),
samples were twice optically cleared in a benzyl alcohol:benzyl
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benzoate solution (ratio 1:2) for 4 h each. Cleared samples were
subsequently imaged by ultramicroscopy.
Immunohistochemistry
Embryos were ﬁxed for 4 h in 4% PFA/PBS, washed in PBS,
embedded and snap-frozen in OCT. In all, 20 mm cryo-sections
were ﬁxed in ice-cold methanol for 10min, washed and blocked
in PermBlock-3 (3% BSA, 0.5% Tween-20 in PBS). Sections were
incubated for 1 h with primary antibodies, washed three times in
PBS-T and ﬁnally incubated in Alexa-dye conjugated secondary
antibodies (Invitrogen). After mounting with mowiol
(Calbiochem, 475904), confocal images were captured using a
Zeiss LSM 510 meta ( 20, NA¼ 0.8) and Zeiss LSM780 (20x,
NA¼ 0.8) confocal microscope.
Antibodies
The following antibodies were used: rabbit polyclonal anti-human
Prox1 (ReliaTech, 102-PA30), goat polyclonal anti-human Prox1
(R&D Systems, AF2727), goat polyclonal anti-mouse VEGFR-3
(R&D Systems, AF743), rat monoclonal anti-mouse PECAM-1
(clone 5D2.6 and clone 1G5.1, provided by Dr S Butz), goat
polyclonal anti-rat Unc5B (R&D Systems, AF1006), rabbit polyclonal
anti-mouse Endomucin (VE44, kindly provided by Prof D
Vestweber), hamster monoclonal anti-mouse Podoplanin (clone
8.1.1, in-house made), rat monoclonal anti-human Integrin a6
(GoH3, R&D, MAB13501), rabbit polyclonal anti-mouse Lyve-1
(ReliaTech, 103-PA50), goat polyclonal anti-human Neuropilin-2
(R&D Systems, AF2215), goat polyclonal anti-mouse Netrin-4
(R&D Systems, AF1132), rat monoclonal anti-mouse VEGFR-2
(clone AVAS 12, Biolegend), rat monoclonal anti-mouse Integrin b1
(clone MB1.2, Millipore) and rabbit polyclonal anti-GFP (Abcam,
ab6556).
Detection of b-galactosidase activity
Embryos between E9.5 and E12.5 were dissected and ﬁxed in a
2% PFA/0.2% glutaraldehyde/PBS solution for 30min at RT. After
washing in PBS, the samples were stained for b-galactosidase
activity overnight at 371C using a b-galactosidase staining kit
(Marker Gene Technologies).
Proliferation assay
Proliferation assays were performed using a Click-it EdU Alexa
Fluor 647 Proliferation kit (Invitrogen) according to manufacturer’s
protocol. In brief, pregnant mice were injected with 3.3mg/kg body
weight EdU (5-ethynyl-20-deoxyuridine). Subsequently, mice were
sacriﬁced and embryos prepared. After ﬁxation, samples were
sectioned and histological cryosections were stained with Click-it
EdU detection reagent and vascular markers. EdU-positive cells
were visualized using a Zeiss LSM780 ( 20, NA¼ 0.8) confocal
microscope.
Statistics
Morphometric analysis of different factors was assessed by quanti-
fying ﬂuorescence intensity in ImageJ with a minimum of n¼ 20
different measuring points in each structure. Structures to be
compared were always analysed in the same confocal image. The
mean of at least N¼ 3 different images was calculated and statisti-
cally evaluated. Data are presented as mean±s.e.m. We analysed
data using Mann–Whitney rank-sum test and Student’s t-test as
indicated in the ﬁgure legends (Sigma Plot 11.0).
For Imaris Vantage analysis of the nuclear shape: Sphericity C
was deﬁned as the ratio of the surface area of a sphere with the
same volume as the particle under investigation to the surface area
of the particle using the formula C¼p1/3ð6VpÞ2/3/Ap, with Vp
(volume of particle); Ap (surface area of particle). Ellipticity e was
deﬁned as the pointedness of a prolate spheroid, that is, one for
which the polar radius (c) is greater than the equatorial radius (a)
e¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
c2 a2
p
/c.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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